Product NDC: | 51672-2030 |
Proprietary Name: | Oxymetazoline Hydrochloride |
Non Proprietary Name: | Oxymetazoline Hydrochloride |
Active Ingredient(s): | .05 g/100mL & nbsp; Oxymetazoline Hydrochloride |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-2030 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20060225 |
Package NDC: | 51672-2030-5 |
Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-5) > 15 mL in 1 BOTTLE, SPRAY |
NDC Code | 51672-2030-5 |
Proprietary Name | Oxymetazoline Hydrochloride |
Package Description | 1 BOTTLE, SPRAY in 1 CARTON (51672-2030-5) > 15 mL in 1 BOTTLE, SPRAY |
Product NDC | 51672-2030 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Oxymetazoline Hydrochloride |
Dosage Form Name | SPRAY |
Route Name | NASAL |
Start Marketing Date | 20060225 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | OXYMETAZOLINE HYDROCHLORIDE |
Strength Number | .05 |
Strength Unit | g/100mL |
Pharmaceutical Classes |